Security key
45256X103
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 427,987
- Total 13F value
- $4,040,197
- Share change
- +113,927
- SEC-reported price per share
- $9.44
- Number of holders
- 7
- Value change
- +$1,075,471
- Number of buys
- 3
- Number of sells
- 2
- Shares outstanding
- 1,150,491,181
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
7
Top holders
7
IBRX full security history
Ownership snapshot
Full 13F holder table
ImmunityBio, Inc. SEC filings
ImmunityBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45256X103
Recent filing periods:
Ownership snapshot
Top reported holders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cambridge Equities, LP
Disclosed value leader
Cambridge Equities, LP
Comparable rows
15/15
Latest evidence
31 Jul 2026
13D/G
3/4/5
13F
Lead comparable stake: 65%
13D/G row: Cambridge Equities, LP
Showing 1-6 of 15 holder rows.
Quick read
Cambridge Equities, LP leads the comparable SEC ownership view at 65%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cambridge Equities, LP's linked filing trail.
Comparable ownership
Top 5
Cambridge Equities, LP
65%
CALIFORNIA CAPITAL EQUITY, LLC
25%
MP 13 Ventures, LLC
25%
Nant Capital, LLC
25%
BlackRock, Inc.
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cambridge Equities, LP |
13D/G
3/4/5
Patrick Soon-Shiong · 10%+ Owner
|
65%
|
$5,807,587,440
745,518,285 shares
|
-$453,152 | 31 Jul 2026 |
| CALIFORNIA CAPITAL EQUITY, LLC |
3/4/5
10%+ Owner
|
25%
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| MP 13 Ventures, LLC |
3/4/5
10%+ Owner
|
25%
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| Nant Capital, LLC |
3/4/5
10%+ Owner
|
25%
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
3%
|
$298,398,958
34,083,262 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
1.9%
|
$187,343,325
21,398,438 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
427,987
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
402
Q3 2026 holders
7
Holder diff
-395
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend